Edesa Biotech (EDSA) Work In Process (2015)
Edesa Biotech's (EDSA) quarterly Work In Process came in at $137021.0 in Q3 2015, up 69.75% quarter-over-quarter from $80720.0 in Q2 2015.
Analysis
Edesa Biotech (EDSA) Work In Process (2015) Analysis & Trends
Edesa Biotech has disclosed Work In Process across 1 years of filings, most recently posting $137021.0 for Q3 2015.
- In Q3 2015, Work In Process changed N/A year-over-year to $137021.0; the TTM figure through Sep 2015 stood at $137021.0 (changed N/A YoY), while the FY2015 annual figure was $137021.0, changed N/A from the prior year.
- Work In Process came in at $137021.0 for Q3 2015 at Edesa Biotech, up from $80720.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $137021.0 in Q3 2015 to a low of $80720.0 in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.59 Bn | 192.60 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.21 Bn | 177.03 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.41 Bn | 123.56 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.94 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.41 Bn | 1.37 Bn |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.83 Bn | 30.54 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn |
| 10 | Edesa Biotech | 43.24 Mn | 43.24 Mn | - |